Warholic, Natalie M

A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells

Knutson, S. K., Wigle, T. J., Warholic, N. M., Sneeringer, C. J., Allain, C. J., Klaus, C. R., Sacks, J. D., Raimondi, A., Majer, C. R., Song, J., et al. (2012) · Nature Chemical Biology

Epigenetics and DNA MethylationCancer-related gene regulation

Cited by 776

EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCL

Brach, D., Johnston-Blackwell, D., Drew, A., Lingaraj, T., Motwani, V., Warholic, N. M., Feldman, I., Plescia, C., Smith, J. J., Copeland, R. A., et al. (2017) · Molecular Cancer Therapeutics

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 70

Pain Intensity and Patientsʼ Acceptance of Surgical Complication Risks With Lumbar Fusion

Bono, C. M., Harris, M. B., Warholic, N., Katz, J. N., Carreras, E., White, A., Schmitz, M., Wood, K. B., & Losina, E. (2013) · Spine

Spine and Intervertebral Disc PathologyMusculoskeletal pain and rehabilitation

Cited by 28